NCT00734149View on ClinicalTrials.gov

Bortezomib With Melphalan and Prednisone for Multiple Myeloma

PHASE2CompletedINTERVENTIONAL

Enrollment

45

Participants

Timeline

Start Date

July 31, 2004

Primary Completion Date

February 29, 2008

Study Completion Date

February 29, 2008

Conditions

Multiple Myeloma

Interventions

DRUG

Bortezomib

DRUG

Melphalan

DRUG

Prednisone

Trial Locations (1)

27710

Duke University Medical Center, Durham

Sponsors

Lead Sponsor

Duke University

All Listed Sponsors

lead

Duke University

OTHER

NCT00734149 - Bortezomib With Melphalan and Prednisone for Multiple Myeloma | Biotech Hunter | Biotech Hunter